Boston, MA -- (SBWIRE) -- 08/26/2013 -- At winstonsmallcap.com we focus on undervalued companies trading under $5. Right now the markets are surging and we are seeing an opportunity in micro-cap companies like we have never seen before. Let have a Look on: (Raptor Pharmaceutical Corp.(NASDAQ:RPTP), Affymetrix, Inc.(NASDAQ:AFFX), Sequenom, Inc. (NASDAQ:SQNM), Northern Tier Energy LP (NYSE:NTI)
Raptor Pharmaceutical Corp.(NASDAQ:RPTP) shares gained 4.93% and closed at $13.51. RPTP’s stock had its price target upped by Canaccord Genuity from $14.00 to $16.00 in a research note issued to investors on August 13. The firm currently has a buy rating on the stock.
The company, on August 8, provided a launch update for PROCYSBI (cysteamine bitartrate) delayed-release capsules and financial results for its second quarter and six months ended June 30, 2013. Net loss for the second quarter ended June 30, 2013 was $24.1 million, or $0.43 per share, compared to a net loss of $3.0 million, or $0.06 per share, for the fiscal quarter ended May 31, 2012. Non-GAAP net loss excluding non-cash warrant expense was $17.1 million, or $0.30 per share for the second quarter of 2013.
How Should Investors Trade RPTP After The Recent Volatility? Get Free Report Here
Affymetrix, Inc.(NASDAQ:AFFX) shares increased 4.16% to $5.51. The company on August 5 announced the launch of the new OncoScan? FFPE Assay Kit, a whole-genome copy number assay for highly degraded FFPE solid tumor samples, at the Cancer Cytogenomics Microarray Consortium conference being held in Chicago.
Additionally, the company on July 31 reported its operating results for the second quarter of 2013. Product revenue for the second quarter of 2013 was $74.2 million and service and other revenue was $5.3 million. For the second quarter of 2013, operating expenses were $45.1 million on a GAAP basis as compared to $54.1 million in 2012.
How Should Investors Trade AFFX After The Recent Volatility? Get Free Report Here
Sequenom, Inc. (NASDAQ:SQNM) shares declined 1.30% to $3.03. SQNM and CombiMatrix Corporation (NASDAQ: CBMX), on August 1 jointly announced that the Sequenom Center for Molecular Medicine LLC (Sequenom CMM) and CombiMatrix have entered into a collaboration agreement to market chromosomal microarray analysis (CMA) testing services to broaden and confirm the results of noninvasive, prenatal testing (NIPT) to physicians and their patients.
Is SQNM A Good Buy After The Recent Price Movement? Find Out Here
Northern Tier Energy LP (NYSE:NTI) shares jumped 0.24% to $20.85. Northern Tier Energy LP and its subsidiaries on August 12 reported results for the second quarter ending June 30, 2013. Net income was $63.9 million compared to $245.6 million for the second quarter of 2012 and Adjusted EBITDA for the second quarter of 2013 was $85.9 million, a decrease of $160.4 million compared to $246.3 million for the second quarter of 2012.
Is NTI A Strong Buy? Get Advantage Of Our Free Trend Analysis Here
Here at Winston we focus on undervalued companies trading under $5. Right now the markets are surging and we are seeing an opportunity in micro-cap companies like we have never seen before. We focus on companies that we feel are trading at a discount to the market for various reasons. Enter your email and track our performance! We are sure you won’t be disappointed.
http://winstonsmallcap.com/and its owners, and their affiliates, directors and officers, and immediate family members, are hereafter collectively referred to as “WSC” or “we” or “us” or “our”). WSC publishes information (the “Information”) about publicly traded companies (the “Profiled Company” or the “Profiled Companies”) which has been obtained from various sources including publicly available sources on the internet. WSC does not undertake any due diligence or investigation of the Information it obtains or publishes.
Read Full Disclaimer at: http://winstonsmallcap.com/disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)